Published by La Vanguardia 2015-12-15. Oncomatryx expands capital to complete the preclinical phase of drugs against tumor stroma The Basque company Oncomatryx has completed a round of capital increase of
War on cancer stroma: a novel pathway to treat pancreatic cancer By Laureano Simon, CEO at Oncomatryx Pancreatic cancer is the fourth most fatal cancer in men and women. Most patients
6th World ADC Summit. 8th-10th February 2016. Berlin (Germany). ONCOMATRYX will be attending World ADC Berlin. Poster Presentation: “OMTX705, a powerful stroma-targeting ADC to treat invasive tumors” by Myriam Fabre, PhD. If you
Tumor microenvironment: A cancer key player to be fired Novel precision drugs that target the tumor microenvironment are entering the battlefield against cancer. Recent advances in the prevention and treatment
10.12.2012 12:33 Uni Stuttgart und Oncomatrix starten Forschungskooperation Andrea Mayer-Grenu Abteilung Hochschulkommunikation Universität Stuttgart Neuer Krebsmedikamente für die Behandlung metastasierender Tumore Das spanische Biopharmazeutik-Unternehmen Oncomatrix und die Universität Stuttgart haben
Spanish Company Oncomatrix Develops a Test That Detects Whether a Breast Cancer Disease Will Develop Metastasis 6/26/2013 9:28:31 AM Get the latest biotech news where you want it. Sign up
Press Release 2013-06-26 DMTXinvascan tested in US hospitals. Hospitals in the USA launch a Basque test to predict the metastasis of breast cancer Current diagnostic systems impede the detection in
Publisehed by El Dato Magazine el 2013-01-01 New treatments against the most invasive cancer Develops in collaboration with renowned public and private national and foreign companies, new drugs that help to
By continuing to use the site, you agree to the use of cookies. Continue, scroll or accept. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.